where to next?, page-283

This stock is remaining on my watch-list and is not one to hold at the moment.

There are too many restrictions on medical cannabis at the moment in the Australian market.

(1) Sales reps have to wait for doctors to approach them.

(2) Only the current GPs can provide a medical cannabis script. 

This basically means the industry is going to have to wait for easing of regulations for the Australian market. 

Projections for medical patients I've seen are 3400 for 2019, 7600 for 2020 and 17600 for 2021. (Cannatech)

Looks like a deliberate process of the govt regulatory braking the Australian cannabis industry. 

Off course, things can change as soon as regulatory change may occur. 

However, it remains speculative but I don't expect much movement in the next 12 months.